Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Natera (NTRA) and Argenx Se (ARGX)
Stifel Nicolaus Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)
Viking Therapeutics Analyst Ratings
Viking Therapeutics Analyst Ratings
Viking Therapeutics Analyst Ratings
Viking Therapeutics Analyst Ratings
Raymond James Upgrades Viking Therapeutics to Strong Buy, Raises Price Target to $116
Viking Therapeutics Analyst Ratings
Viking Therapeutics (VKTX) Receives a Buy From Truist Financial
Viking Therapeutics (VKTX) Gets a Buy From Truist Financial
Analysts Conflicted on These Healthcare Names: Viking Therapeutics (VKTX) and Bristol-Myers Squibb (BMY)
Buy Rating Affirmed for Viking Therapeutics Amidst Strong Clinical Progress and Strategic Moves
Viking Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Acrivon Therapeutics, Inc. (ACRV) and Gain Therapeutics (GANX)
Viking Therapeutics Stock (NASDAQ:VKTX): Analysts Stay Bullish on 2024's Top Mid-Cap
Buy Rating Affirmed for Viking Therapeutics Amid Promising Obesity Drug Trials and Strategic Market Positioning
Stifel Nicolaus Remains a Buy on Viking Therapeutics (VKTX)
Buy Rating Upheld for Viking Therapeutics as VK2735 Shows Promising Clinical Results in Obesity Management
Truist Financial Sticks to Their Buy Rating for Viking Therapeutics (VKTX)
Viking Therapeutics Analyst Ratings